Literature DB >> 7511637

Selective expansion of cytotoxic T lymphocytes with a CD4+CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with Hepatitis B virus.

V Barnaba1, A Franco, M Paroli, R Benvenuto, G De Petrillo, V L Burgio, I Santilio, C Balsano, M S Bonavita, G Cappelli.   

Abstract

Highly purified CD4+ T cells isolated from liver biopsies of patients with hepatitis B virus-induced CAH had a strong cytotoxic activity and were comprised of a substantial number of cells (25%-40%) expressing CD56 surface marker. These cells were absent in CD4+ T cells from the peripheral blood of CAH patients or normal controls and these suspensions did not have cytotoxic activity. CD4+CD56+ T cells were further characterized by studies at the clonal level. A total of 71 hepatitis B envelope antigen-specific CD4+ T cell clones was investigated (23 from liver biopsies, 48 from peripheral blood of patients or normal vaccinated individuals). A total of 16 out of 23 (69.5%) of the clones from liver biopsies, but only 4.1% (2 out of 48) of those from PBLs, expressed CD56. A clone was defined as CD56+ when 40% or more of the cells expressed the marker. Production of TNF-alpha, IL-4, IL-5, IL-2, and IFN-gamma was investigated in 15 CD4+CD56+ and in 18 CD4+CD56- T cell clones, which shared the same HLA restriction element (DR2w15) and the same fine specificity (peptide 193-207 of the S region). All of the clones from the two groups released TNF-alpha and IL-2. However, all of the CD4+CD56+ T cell clones produced IFN-gamma but not IL-4 and IL-5 (Th1-like cell clones). Fourteen of the CD4+CD56- clones released IFN-gamma, IL-4, and IL-5 (Th0-like cell clones); three produced IL-4 and IL-5 but not IFN-gamma (Th2-like cell clones); and only one had a Th1 cytokine secretion profile. Cell fractionating studies within single CD4+CD56+ T cell clones showed that cells expressing high density CD56 had a stronger cytotoxic activity and produced higher levels of IFN-gamma than cells with low density CD56, thus further supporting a correlation between CD56 expression and cell functions. The results indicate that: 1) in CAH patients, cytotoxic CD4+ T cells with a Th1 cytokine secretion profile are compartmentalized in the liver, 2) these cells may be identified by the expression of CD56, 3) the expansion of these cells may be facilitated by antigenic stimulation within the inflammatory environment of the liver, and 4) CD4+CD56+ cells may play a pathogenetic role in hepatitis B virus infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7511637

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

1.  Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines.

Authors:  I Desombere; Y Gijbels; A Verwulgen; G Leroux-Roels
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

2.  Immune response against HBsAg vaccine.

Authors:  Maria Cristina Honorati; Andrea Facchini
Journal:  World J Gastroenterol       Date:  1998-12       Impact factor: 5.742

Review 3.  Review of cytokine profiles in patients with hepatitis.

Authors:  Qiao-Ling Sun; Wei Ran
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

4.  CD56+ T cells inhibit HIV-1 infection of macrophages.

Authors:  Wei Hou; Li Ye; Wen-Zhe Ho
Journal:  J Leukoc Biol       Date:  2012-05-16       Impact factor: 4.962

5.  Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles.

Authors:  R Nisini; M Paroli; D Accapezzato; F Bonino; F Rosina; T Santantonio; F Sallusto; A Amoroso; M Houghton; V Barnaba
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 6.  Cytotoxic T cells and viral hepatitis.

Authors:  F V Chisari
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

7.  A new vaccine escape mutant of hepatitis B virus causes occult infection.

Authors:  Qing Ye; Shi-Qiang Shang; Wei Li
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

8.  Increased numbers and functional activity of CD56⁺ T cells in healthy cytomegalovirus positive subjects.

Authors:  Mazen Almehmadi; Brian F Flanagan; Naeem Khan; Suliman Alomar; Stephen E Christmas
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

9.  HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release.

Authors:  M J Koziel; D Dudley; N Afdhal; A Grakoui; C M Rice; Q L Choo; M Houghton; B D Walker
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

10.  Anti-human cytomegalovirus activity of cytokines produced by CD4+ T-cell clones specifically activated by IE1 peptides in vitro.

Authors:  J L Davignon; P Castanié; J A Yorke; N Gautier; D Clément; C Davrinche
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.